| ID | Name | CAS | Data |
log10WS |
| 32-595-6 |
Butyl ([1,1,3,3-tetramethyl-3-(pyridin-3-ylmethoxy)disiloxanyl]oxy)acetate
|
|
4 | -2.00 |
| 33-052-7 |
21-Hydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | -5.17 |
| 33-098-7 |
2H-1-Benzopyran-2-one, 7-[(3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-
|
495-02-3 |
4 | -5.54 |
| 33-284-0 |
4-Methyl-N-((4-methyl-1-piperazinyl)carbonyl)-benzenesulfonamide, N-methyl-
|
|
4 | -1.66 |
| 33-499-2 |
O-(2,4,5-trichlorophenyl) n,n,n',n'-tetramethyldiamidothiophosphate
|
|
4 | -5.65 |
| 33-902-3 |
1H-Pyrrole-2-carboxylic acid, 3,5-dimethyl-4-nitro-, ethyl ester
|
5463-44-5 |
4 | -3.09 |
| 35-066-0 |
3-«beta»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | -6.65 |
| 35-475-6 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»-diol, bis-TMS
|
|
4 | -6.88 |
| 35-516-0 |
3«beta»-Hydroxy-7«beta»-methoxycholanic acid, methyl ester, TMS
|
|
4 | -5.91 |
| 35-612-3 |
5.beta.-Androstan-3.alpha.,11.beta.-diol-17-one (Androsterone), MO
|
|
4 | -3.57 |
| 35-705-0 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,7-«alpha»-trihydroxy, methyl ester, TMS
|
|
4 | -6.95 |
| 36-008-3 |
2-Acetamido-2-([(trimethylsilyl)oxy]methyl)propane-1,3-diyl diacetate
|
|
4 | -1.06 |
| 36-739-2 |
17«alpha»-Methyl-17«beta»-hydroxy-1,4-androstadien-3-one, trimethylsilyl deriv.
|
41235-52-3 |
4 | -5.10 |
| 37-043-3 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17keto,4«alpha»-ol, monoTBDMS
|
|
4 | -6.50 |
| 37-781-4 |
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3«alpha»,14«alpha»,16«alpha»)-
|
6835-99-0 |
4 | -3.33 |
| 37-814-7 |
Cholan-24-oic acid, 3,12-bis[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»,12«alpha»)-
|
6818-41-3 |
4 | -6.65 |
| 38-312-3 |
3-Hydroxy-2-phenyl-propionic acid 6-hydroxy-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester
|
|
4 | -1.48 |
| 38-835-3 |
5-Hydroxyindole-3-acetic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | -5.22 |
| 39-541-8 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | -4.72 |
| 39-674-1 |
3-.beta.,19-Dihydroxy-5-androsten-17-one, MO TMS
|
|
4 | -5.03 |
| 39-938-8 |
3«alpha»,12«beta»-Dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
4 | -6.65 |
| 40-031-2 |
3-«beta»,12-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | -6.65 |
| 40-191-5 |
2-Propanone, [(9-beta-d-ribofuranosyl-9h-purin-6-yl)thio]-
|
|
4 | -1.89 |
| 40-587-6 |
Cinchonan-9-ol, 10,11-dihydro-6'-methoxy-, (8«alpha»,9R)-
|
522-66-7 |
4 | -3.06 |
| 40-908-9 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one, O-trimethylsilyl
|
18880-80-3 |
4 | -5.59 |
| 40-944-9 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, O-methyloxime, (17«beta»)-
|
56210-83-4 |
4 | -5.26 |
| 40-956-6 |
2-Imidazolidinone, 3-[5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl]-4-hydroxy-1-methyl-
|
55511-98-3 |
4 | [-1.88; -1.88] |
| 41-139-2 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»,5«beta»)-
|
10426-96-7 |
4 | -5.40 |
| 41-590-1 |
2-keto,3-methyl-5.alpha.-androstan-17.beta.-ol, monoTMS
|
|
4 | -5.66 |
| 42-130-0 |
Androst-4-en-17«alpha»-methyl-17«beta»-ol-3-one, TMS
|
|
4 | -6.12 |
| 42-377-7 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS(d9)
|
|
4 | -4.72 |
| 42-488-4 |
5-«alpha»-Pregnane-17-«alpha»,20-«alpha»-diol, bis-TMS
|
|
4 | -6.88 |
| 42-492-9 |
5«beta»-Androstane-3,17-dione, mono-TMS, (2-en)
|
|
4 | -5.53 |
| 42-738-6 |
5«beta»-pregnane-3«alpha»,17«alpha»,20«beta»-triol, 17,20-methylboronate
|
|
4 | -4.80 |
| 42-986-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | -7.40 |
| 43-393-8 |
(17«beta»)-2,3-Dimethoxy-17-[(trimethylsilyl)oxy]estra-1(10),2,4-triene
|
|
4 | -5.47 |
| 44-273-0 |
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-
|
50-35-1 |
4 | [-2.68; -2.68] |
| 45-215-3 |
6-Chloro-2-methyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
|
90606-97-6 |
4 | -3.47 |
| 45-216-2 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, TMS
|
|
4 | -5.29 |
| 45-619-5 |
3-«alpha»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | -6.65 |
| 45-802-1 |
3«alpha»,12«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | -7.49 |
| 46-390-8 |
3«beta»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | -6.95 |
| 46-416-9 |
5«beta»-Androstan-3«alpha»-ol-11,17-dione, MO
|
|
4 | -3.66 |
| 46-908-3 |
3«alpha»,7«beta»-Dihydroxy-5«beta»-homocholanoic acid, MeTMS
|
|
4 | -6.86 |
| 47-657-1 |
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
|
|
4 | -3.73 |
| 48-043-1 |
O,O-Dimethyl O-(2,4,5-trichloro)phenyl phosphate
|
3983-45-7 |
4 | -3.55 |
| 48-545-4 |
Carbamic acid, dimethyl-, 2-(formylmethylamino)-5,6-dimethyl-4-pyrimidinyl ester
|
27218-04-8 |
4 | -1.60 |
| 49-566-0 |
Androst-2,4-dien-3,17«beta»-diol, (3,17-O)-diTBDMSi
|
|
4 | -7.27 |
| 49-725-3 |
N-isobutyl-2-(trimethylsilyloxy]-4,5-dihydro-1H-imidazole-1-carboxamide
|
|
4 | -2.46 |
| 50-109-5 |
2H-1-Benzopyran-2-one, 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthalenyl)-
|
5836-29-3 |
4 | -2.84 |
| 50-501-9 |
5«beta»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-89-9 |
4 | -5.53 |
| 50-917-8 |
Silane, [[(17«beta»)-2-methoxyestra-1,3,5(10)-triene-3,17-diyl]bis(oxy)]bis[trimethyl-
|
29825-47-6 |
4 | -5.98 |
| 51-409-1 |
17-Epimetandienone (Androst-1,4-dien-17B-methyl-17A-ol-3-one), TMS
|
|
4 | -5.10 |
| 51-755-7 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, methylboronate
|
|
4 | -4.32 |
| 52-766-4 |
5«beta»-Cholane-3«alpha»,7«alpha»,24-triol, TMS
|
|
4 | -7.73 |
| 53-503-4 |
Methyl 17A-hydroxy-3-oxoandrost-4-ene-17B-carboxylate, 3-MO
|
|
4 | -4.22 |
| 53-570-0 |
17.alpha.,21-Dihydroxypregn-4-en-3,20-dione, 17,21-dimethylsilylene
|
|
4 | -4.55 |
| 53-652-9 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | -5.29 |
| 54-943-5 |
O-methyl,o-(2,4,5,-trichlorophenyl)-tert-butyl phosphoramidothioate
|
16805-76-8 |
4 | -6.15 |
| 56-004-5 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, bis-TMS
|
|
4 | -5.00 |
| 56-144-0 |
3«alpha»-hydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | -7.11 |
| 56-164-8 |
5«beta»-Androst-1-ene-3,17-dione, mono-TMS
|
|
4 | -5.65 |
| 56-753-4 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-4-one, dodecahydro-, [7S-(7«alpha»,7a«alpha»,14«alpha»,14a«alpha»)]-
|
486-87-3 |
4 | -1.63 |
| 57-129-6 |
2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-dimethyl-
|
|
4 | -2.13 |
| 57-666-0 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, (17«alpha»)-
|
16134-45-5 |
4 | -5.09 |
| 59-880-0 |
Methyltestosterone (Androst-4-en-17A-methyl-17B-ol-3-one), TMS
|
|
4 | -6.12 |
| 60-846-6 |
9H-purine, 6-chloro-9-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-
|
39824-26-5 |
4 | -2.61 |
| 60-850-1 |
Phosphorothioic acid, O,O-diethyl O-(p-methylsulfonyl)phenyl ester
|
14255-72-2 |
4 | -3.98 |
| 62-409-9 |
N-tert-Butyl-N'-trimethylsilyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
4 | -3.90 |
| 62-475-6 |
3-«beta»,17-«beta»-Dihydroxy-5-androsten-16-one, TMS
|
|
4 | -5.34 |
| 62-557-5 |
Phosphoramidothioic acid, o-ethyl-o-(2,4,5-trichlorophenyl) ester
|
2775-95-3 |
4 | -5.64 |
| 63-477-3 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, tris-TMS
|
|
4 | -7.02 |
| 64-045-1 |
1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol, trimethylsilyl- ether
|
|
4 | -4.37 |
| 64-108-1 |
5-Chloro-N-(2-chloro-4-nitro-phenyl)-N-trimethylsilyl-2-trimethylsilyloxybenzamide
|
|
4 | -5.94 |
| 64-392-6 |
[1,3,5]Triazine-2,4-diamine, 6-chloro-N,N'-dicycloheptyl-
|
|
4 | -6.48 |
| 64-949-8 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«beta»-triol, methylboronate
|
|
4 | -4.64 |
| 65-250-2 |
3«alpha»,16«beta»-Dihydroxy-5-androsten-17-one, di-TMS
|
|
4 | -5.29 |
| 65-325-9 |
Estra-1,3,5(10)-trien-17-one, 2-methoxy-3-[(trimethylsilyl)oxy]-
|
29825-40-9 |
4 | -5.13 |
| 65-893-9 |
Androstane-11,17-dione, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
5042-90-0 |
4 | -4.56 |
| 66-380-7 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, methylboronate
|
|
4 | -5.34 |
| 66-828-0 |
O-methyl,o-(2,4,5-trichlorophenyl)n-ethyl phosphoramidothioate
|
|
4 | -5.43 |
| 66-881-1 |
Ethanimidothioic acid, 2-(dimethylamino)-N-hydroxy-2-oxo-, methyl ester
|
30558-43-1 |
4 | 0.15 |
| 67-060-1 |
4-Androsten-17«beta»-ol-3-one (testosterone), MO-TMS
|
|
4 | -5.26 |
| 67-507-5 |
3«alpha»,7«beta»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | -7.40 |
| 67-626-3 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«alpha»,5«alpha»)-
|
57711-45-2 |
4 | -5.93 |
| 67-973-8 |
2,3,16,17-Tetrakis[(trimethylsilyl)oxy]estra-1,3,5(10)-triene, (16«alpha»,17«beta»)-
|
51497-46-2 |
4 | -7.03 |
| 68-176-2 |
2H-1-Benzopyran-2-one, 7-methoxy-8-(3-methylbutyl)-
|
|
4 | -4.18 |
| 69-642-3 |
3«alpha»,6«alpha»-Dihydroxy-5«beta»-cholanic acid, methyl ester, TMS
|
|
4 | -6.52 |
| 70-211-9 |
3«alpha»-Hydroxy-5«beta»-pregnan-20-one, O-trimethylsilyl
|
18880-83-6 |
4 | -5.59 |
| 70-529-7 |
Cholanic acid, 3«alpha»,6«alpha»,7«alpha»-trihydroxy, Me-TMS
|
|
4 | -6.81 |
| 70-904-0 |
Phosphorothioic acid, O-[5-chloro-1-(1-methylethyl)-1H-1,2,4-triazol-3-yl] O,O-diethyl ester
|
42509-80-8 |
4 | -4.46 |
| 71-157-9 |
Silane, [[(3«beta»,17«beta»)-17-methylandrost-5-ene-3,17-diyl]bis(oxy)]bis[trimethyl-
|
39780-59-1 |
4 | -6.06 |
| 71-481-9 |
17«beta»-Hydroxy-5«alpha»-androstan-3-one, trimethylsilyl ether
|
18899-43-9 |
4 | -5.41 |
| 71-643-9 |
Pregn-5-en-20-one, 3«beta»-(trimethylsiloxy)-, O-methyloxime
|
25830-38-0 |
4 | -5.29 |
| 71-785-2 |
4-(2,3-Dihydroxy-3-methylbutoxy)furo(3,2-g)chromen-7-one
|
24724-52-5 |
4 | -2.88 |
| 72-834-6 |
1,3,5(10)-Oestratriene-3,17.beta.-diol, 3-TBDMS-17-HFB
|
|
4 | -8.11 |
| 74-453-7 |
(R)-9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo(3,2-g)(1)benzopyran-7-one
|
482-25-7 |
4 | -2.79 |
| 75-216-9 |
4H-1-BENZOPYRANE-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-
|
|
4 | -3.67 |
| 77-059-2 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-4-one, dodecahydro-2-hydroxy-, [2S-(2«alpha»,7«alpha»,7a«beta»,14«alpha»,14a«alpha»)]-
|
23360-87-4 |
4 | -0.94 |
| 77-092-5 |
2H-1-Benzopyran-2-one, 7,8-dihydroxy-6-methoxy-
|
574-84-5 |
4 | -1.83 |
|
« Previous Results
Next Results »
|